Hepatitis C virus (HCV) is one of the leading causes of chronic liver disease, cirrhosis, and
hepatocellular carcinoma, resulting in major global public health concerns. The HCV …

Background According to published reports from the World Health Organization, it is
estimated that more than 3% of the world's population is infected with HCV. Given the impact …

Background Hepatitis C virus (HCV) has a high prevalence worldwide, and the progression
of the disease can cause irreversible damage to severe liver damage or even death …

Abstract Background & Aims Chronic infection with hepatitis B and C viruses (HBV & HCV) is
a major contributor to liver disease and liver‐related mortality in Uzbekistan. There is a need …

Background. Viral hepatitis is a major burden for the healthcare system worldwide. Up to
date, a comprehensive analysis of the prevalence of viral hepatitis in Kazakhstan and …

A bidirectional negative relationship between Hepatitis C virus (HCV) replication and gene
expression of the catecholamine biosynthetic enzyme L-Dopa decarboxylase (DDC) was …

Aim To estimate the prevalence of hepatitis C virus (HCV) infection in patients with end-
stage renal disease (ESRD) undergoing hemodialysis in Latin America and the Caribbean …

ABSTRACT BACKGROUND: Viral hepatitis is a global phenomenon, with the disease
burden varying on a daily basis. Amongst chronic infections, hepatitis B virus and hepatitis C …

In “Integrating HCV testing with HIV programs improves hepatitis C outcomes in people who
inject drugs: A clusterrandomized trial”, 1 the authors studied an intervention that integrated …

Objective The emergence of resistance-associated substitutions (RASs) poses a significant
challenge to the effective treatment of hepatitis C virus (HCV) infection using direct-acting …